Picture BIO Deutschland German Corona Special 2021 Digital 650x80px
Organisation › Details

AstraZeneca plc (LSE: AZN)

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. *


Period Start 1999-04-05 merged
  Group AstraZeneca (Group)
  Predecessor Zeneca Group Plc
Product Industry pharmaceutical
Persons Person Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO)
  Person 2 Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK)
Region Region London, Greater London
  Country United Kingdom (GB)
  Street 15 Stanhope Gate
  City W1K 1LN London
  Tel +44-20-7304-5000
    Address record changed: 2020-12-02
Basic data Employees I: 50,001 to 100,0 (2019-12-31)
  Currency USD
  Annual sales 24,384,000 (revenue, total, consolidated (2019) 2019-12-31)
  Profit 1,227,000,000 (2019-12-31)
  Cash 5,369,000,000 (2019-12-31)
    * Document for �About Section�: 
Record changed: 2021-02-17


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for AstraZeneca (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top